FDA: increased risk of serious pancreatitis with irritable bowel drug Viberzi in patients without a gallbladder
The FDA ( U.S. Food and Drug Administration ) is warning that Viberzi ( Eluxadoline ), a medicine used to treat irritable bowel syndrome with diarrhea ( IBS-D ), should not be used in patients who do ...
read article